AUSTIN, Texas, Dec. 13, 2017 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the fourth quarter of 2017 of $0.06 per share of common stock payable on January 12, 2018 to stockholders of record as of the close of business on December 22, 2017.
About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.
Sr. Vice President of Finance and CFO
Sr. Director, Investor Relations
SOURCE Luminex Corporation